SEDANA — Sedana Medical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK946.68m
- SEK913.23m
- SEK200.23m
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln
Brief: Sedana Medical Q2 Sales SEK 49.1 Million
Brief: Sedana Medical Mikael Haag Takes Office As CFO
Brief: Sedana Medical Files FDA Approval Application For Isoflurane
Sweden's Sedana Medical Q1 sales fall 7% due to lower ICU patient volumes
Brief: Sedana Medical Q1 Sales SEK 53.4 Million
Sweden's Sedana Medical Q4 sales rise on EU growth
Brief: Sedana Medical Proposes That No Dividend Is Paid For 2025
Brief: Sedana Medical Appoints Mikael Haag As CFO
Brief: CFO Johan Spetz To Leave Sedana Medical
Brief: Sedana Medical Q3 Sales SEK 41.2 Million
Brief: Sedana Medical Q2 Sales SEK 49.8 Million
Brief: Sedana Medical U.S. Studies Meet First Key Secondary Endpoint
Brief: Sedana Medical Q1 EBITDA Loss SEK 0.6 Mln
Brief: Sedana Medical Q1 Sales SEK 57.5 Million
Brief: Sedana Medical Receives FDA Approval For Early Access Program In U.S.